Saltar al contenido
MilliporeSigma

Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2015-02-24)
Yubo Cao, Jinglei Qu, Ce Li, Dan Yang, Kezuo Hou, Huachuan Zheng, Yunpeng Liu, Xiujuan Qu
RESUMEN

Mammalian target of rapamycin (mTOR) has emerged as a new potential therapeutic target for gastric cancer. However, a phase III clinical trial found that monotherapy with the mTOR inhibitor everolimus did not significantly improve the overall survival of patients with advanced gastric cancer. This has led to the exploration of more effective combinatorial regimens to enhance the effectiveness of mTOR inhibitors. Here, we demonstrate that Akt phosphorylation is increased in the rapamycin-resistant gastric cancer cell lines MGC803 and SGC7901. We further show that combined treatment with celecoxib and rapamycin results in an additive inhibitory effect on the growth of gastric cancer cells through suppression of rapamycin-induced Akt activation. Moreover, celecoxib upregulated the expression of the ubiquitin ligase casitas B-lineage lymphoma-b (Cbl-b). Knockdown of Cbl-b significantly attenuated celecoxib-mediated inhibition of Akt phosphorylation and impaired the additive anticancer effect of celecoxib and rapamycin. Our results suggest that celecoxib-mediated upregulation of Cbl-b is responsible, at least in part, for the additive antitumor effect of celecoxib and rapamycin via inhibition of rapamycin-induced Akt activation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dimetilsulfóxido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, for molecular biology
Sigma-Aldrich
Dimetilsulfóxido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Dimetilsulfóxido, anhydrous, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Dimetilsulfóxido, PCR Reagent
Sigma-Aldrich
Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Sigma-Aldrich
Dimetilsulfóxido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5%
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
Dimetilsulfóxido, JIS special grade, ≥99.0%
Sigma-Aldrich
Dimetilsulfóxido, suitable for HPLC
Sigma-Aldrich
Dimetilsulfóxido, Vetec, reagent grade, 99%
Sigma-Aldrich
Dimetilsulfóxido, SAJ first grade, ≥99.0%
Sigma-Aldrich
Dimetilsulfóxido, ≥99.0%, suitable for absorption spectrum analysis
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Cblb
Sigma-Aldrich
MISSION® esiRNA, targeting human CBLB